Insider · CIK 0001250379
Michael S Perry
Files at ARWR (ARROWHEAD PHARMACEUTICALS, INC.). First filing Dec 9, 2025, latest Aug 20, 2026.
In brief
Michael S Perry files SEC Form 4 as director at ARWR (ARROWHEAD PHARMACEUTICALS, INC.). Since Dec 9, 2025, Michael S Perry has reported 0 open-market buys worth $0 and 2 open-market sells worth $2.0M, the latest filed on Aug 20, 2026.
A track record needs three past buys with six months of prices behind them; Michael S Perry has 0, so none is measured yet.
The newest scored trade: sold $1.0M of ARWR on Aug 18, 2026, filed Aug 20, 2026, scored 48 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $2.0M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ARWR: ARROWHEAD PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | ARROWHEAD PHARMACEUTICALS, INC. | $1.0M 11,600 shares | -9% | +343% from low-2% from high | |
| 60Notable | ARROWHEAD PHARMACEUTICALS, INC. | $992k 16,250 shares | -12% | +515% from low-6% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 18, 2026 | ARWR Arrowhead Pharmaceuticals Inc. | 11,600 0.01% of outstanding | $1.0M | Aug 18, 2026 | none |
| Dec 5, 2025 | ARWR Arrowhead Pharmaceuticals | 16,250 0.01% of outstanding | $991k | Dec 5, 2025 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -11,600 | $87.30 | $1.0M | 111,459 | Aug 20, 2026 |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +7,819 | $0.00 | $0 | 123,059 | Dec 18, 2025 |
| Dec 5, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -16,250 | $61.03 | $992k | 115,240 | Dec 9, 2025 |
| Dec 18, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +16,733 | $22.99 | $385k | 131,490 | Dec 20, 2024 |
| Dec 15, 2023 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +14,987 | $25.41 | $381k | 114,754 | Dec 19, 2023 |
Questions about Michael S Perry
Answered from the filings on this page, as of the latest one.
Is Michael S Perry buying or selling?
In the last 12 months Michael S Perry reported 0 open-market buys worth $0 and 2 open-market sells worth $2.0M on SEC Form 4; the latest was sold $1.0M of ARWR on Aug 18, 2026. Grants, option exercises and tax withholding are not counted.
How did Michael S Perry's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael S Perry has 0.
Where does Michael S Perry file Form 4?
Michael S Perry has filed Form 4 at ARWR (ARROWHEAD PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.